Search

As COVID-19 was declared a health emergency in March 2020, there was immense demand for information about the novel pathogen. This paper examines the clinician-reported impact of Project ECHO COVID-19 Clinical Rounds on clinician learning. Primary sources of study data were Continuing Medical Education (CME) Surveys for each session from the dates of March 24, 2020 to July 30, 2020 and impact surveys conducted in November 2020, which sought to understand participants’ overall assessment of sessions. Quantitative analyses included descriptive statistics and Mann-Whitney testing. Qualitative data were analyzed through inductive thematic analysis. Clinicians rated their knowledge after each session as significantly higher than before that session. 75.8% of clinicians reported they would ‘definitely’ or ‘probably’ use content gleaned from each attended session and clinicians reported specific clinical and operational changes made as a direct result of sessions. 94.6% of respondents reported that COVID-19 Clinical Rounds helped them provide better care to patients. 89% of respondents indicated they ‘strongly agree’ that they would join ECHO calls again.COVID-19 Clinical Rounds offers a promising model for the establishment of dynamic peer-to-peer tele-mentoring communities for low or no-notice response where scientifically tested or clinically verified practice evidence is limited.

Shock is failure of the circulatory system to provide the organ perfusion and tissue oxygenation required to meet cellular metabolic demands. Traumatic shock is most commonly associated with haemorrhage, however the trauma patient may present with non-haemorrhagic shock. The ‘lethal triad' of acute coagulopathy, metabolic acidosis and hypothermia seen in trauma patients is developing the current approach to management of traumatic shock. The ‘ABCDE' paradigm involves recognition of shock in a primary survey with simultaneous initiation of treatment. Hypotensive resuscitation involves limited volume replacement, during which time poor end-organ perfusion is tolerated, in order to prevent clot dislodgement and re-bleeding. Evidence now suggests that aggressive correction of coagulopathy associated with trauma will help reduce transfusion requirements, decrease bleeding and improve overall outcome. Ratios of packed red blood cells to fresh frozen plasma and platelets closer to 1:1:1 appear to improve outcome and reduce mortality. Damage control resuscitation encompasses key resuscitative strategies including damage control surgery, hypotensive resuscitation and the use of blood products as primary resuscitative fluids to correct coagulopathy. ‘Horizontal' trauma team assessment with assigned roles including a designated leader, improves outcome when managing the trauma patient.